In 1984, hypomethylation of c-Myc was first demonstrated in cancer cells cultured in vitro and was subsequently identified in a variety of malignant tumors, such as hepatocellular carcinoma, leukemia, gastric cancer, and colorectal cancer (Cheah et al., 1984; Guinney et al., 2015). This evidence concerns the gene MYC and cancer.